These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28867759)

  • 1. Development and Optimization of Orally and Topically Applied Liquid Crystal Drug Formulations.
    Kadhum WR; Hada T; Hijikuro I; Todo H; Sugibayashi K
    J Oleo Sci; 2017; 66(9):939-950. PubMed ID: 28867759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Chemical Enhancer Approach for Transdermal Drug Delivery with C
    Kadhum WR; Sekiguchi S; Hijikuro I; Todo H; Sugibayashi K
    J Oleo Sci; 2017 May; 66(5):443-454. PubMed ID: 28381773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of liquid-crystal oral formulations to enhance the bioavailability and skin tissue targeting of p-amino benzoic acid as a model compound.
    Kadhum WR; Oshizaka T; Ichiro H; Todo H; Sugibayashi K
    Eur J Pharm Sci; 2016 Jun; 88():282-90. PubMed ID: 27072433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Evaluation of Biocompatible Topical Petrolatum-liquid Crystal Formulations with Enhanced Skin Permeation Properties.
    Al-Zuhairy SAS; Kadhum WR; Alhijjaj M; Kadhim MM; Al-Janabi AS; Salman AW; Al-Sharifi HKR; Khadom AA
    J Oleo Sci; 2022 Mar; 71(3):459-468. PubMed ID: 35173089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of liquid-crystal formulations with skin-permeation-enhancing abilities for entrapped drugs.
    Yamada K; Yamashita J; Todo H; Miyamoto K; Hashimoto S; Tokudome Y; Hashimoto F; Sugibayashi K
    J Oleo Sci; 2011; 60(1):31-40. PubMed ID: 21178315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of a model hydrophilic high molecular weight compound from injectable non-lamellar liquid crystal formulations containing different types of phospholipids.
    Okada A; Todo H; Hijikuro I; Itakura S; Sugibayashi K
    Int J Pharm; 2020 Mar; 577():118944. PubMed ID: 31870952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations.
    See GL; Arce F; Dahlizar S; Okada A; Fadli MFBM; Hijikuro I; Itakura S; Katakura M; Todo H; Sugibayashi K
    J Control Release; 2020 Sep; 325():1-9. PubMed ID: 32598958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Skin Permeation of a Hydrophilic Drug from Acryl-Based Pressure-Sensitive Adhesive Tape.
    Suzuki T; Aoki T; Saito M; Hijikuro I; Itakura S; Todo H; Sugibayashi K
    Pharm Res; 2021 Feb; 38(2):289-299. PubMed ID: 33515137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Spray Formulations Applied to the Oral Mucosa Using Non-lamellar Liquid Crystal-Forming Lipids.
    Sugibayashi K; Yamamoto N; Itakura S; Okada A; Hijikuro I; Todo H
    Chem Pharm Bull (Tokyo); 2020; 68(11):1025-1033. PubMed ID: 33132369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
    Rajabalaya R; Musa MN; Kifli N; David SR
    Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
    Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
    Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical ultraviolet absorbers topically applied in a skin barrier mimetic formulation remain in the outer stratum corneum of porcine skin.
    Haque T; Crowther JM; Lane ME; Moore DJ
    Int J Pharm; 2016 Aug; 510(1):250-4. PubMed ID: 27321112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and characterization of liquid crystal systems containing azelaic acid for topical delivery.
    Aytekin M; Gursoy RN; Ide S; Soylu EH; Hekimoglu S
    Drug Dev Ind Pharm; 2013 Feb; 39(2):228-39. PubMed ID: 22480294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention.
    Tian Q; Quan P; Fang L; Xu H; Liu C
    Int J Pharm; 2021 Oct; 608():121082. PubMed ID: 34506925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of Novel Liquid Crystal (LC) Formulations with Skin-Permeation-Enhancing Abilities of
    Kósa D; Pető Á; Fenyvesi F; Váradi J; Vecsernyés M; Gonda S; Vasas G; Fehér P; Bácskay I; Ujhelyi Z
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin disposition of drugs after topical application in hairless rats.
    Yanagimoto G; Hayashi T; Hasegawa T; Seki T; Juni K; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):749-54. PubMed ID: 10399833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
    Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
    Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of microemulsions as prolonged-release injectables through in-situ phase transition.
    Wu Z; Alany RG; Tawfeek N; Falconer J; Zhang W; Hassan IM; Rutland M; Svirskis D
    J Control Release; 2014 Jan; 174():188-94. PubMed ID: 24316265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model.
    Van Bocxlaer K; Yardley V; Murdan S; Croft SL
    J Pharm Pharmacol; 2016 Jul; 68(7):862-72. PubMed ID: 27230300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.